Cargando…
The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field
The clinical evaluation of convalescent plasma (CP) for the treatment of Ebola virus disease (EVD) in the current outbreak, predominantly affecting Guinea, Sierra Leone, and Liberia, was prioritized by the World Health Organization in September 2014. In each of these countries, nonrandomized compara...
Autores principales: | van Griensven, Johan, De Weiggheleire, Anja, Delamou, Alexandre, Smith, Peter G., Edwards, Tansy, Vandekerckhove, Philippe, Bah, Elhadj Ibrahima, Colebunders, Robert, Herve, Isola, Lazaygues, Catherine, Haba, Nyankoye, Lynen, Lutgarde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678103/ https://www.ncbi.nlm.nih.gov/pubmed/26261205 http://dx.doi.org/10.1093/cid/civ680 |
Ejemplares similares
-
Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014–2015 outbreak
por: Edwards, Tansy, et al.
Publicado: (2016) -
Organizing the Donation of Convalescent Plasma for a Therapeutic Clinical Trial on Ebola Virus Disease: The Experience in Guinea
por: Delamou, Alexandre, et al.
Publicado: (2016) -
Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015
por: van Griensven, Johan, et al.
Publicado: (2016) -
What motivates Ebola survivors to donate plasma during an emergency clinical trial? The case of Ebola-Tx in Guinea
por: Ronse, Maya, et al.
Publicado: (2018) -
The Plasma Mobile, ‘A gift from heaven’: The impact of health technology transfer on trial perceptions and expectations during the Ebola-Tx Trial, Conakry
por: Marí Sáez, Almudena, et al.
Publicado: (2020)